Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A mitomycin-N6-deoxyadenosine adduct isolated from DNA

Y Palom1, R Lipman, S M Musser

  • 1Department of Chemistry, Hunter College, City University of New York, New York 10021, USA.

Chemical Research in Toxicology
|April 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mass spectrometry and good laboratory practices.

Journal of the American Society for Mass Spectrometry·2013
Same author

Reductive activation of mitomycin A by thiols.

Organic letters·2001
Same author

Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity.

Biochemistry·2001
Same author

Selective activation of mitomycin A by thiols to form DNA cross-links and monoadducts: biochemical basis for the modulation of mitomycin cytotoxicity by the quinone redox potential.

Journal of medicinal chemistry·2001
Same author

Determination of ephedrine-type alkaloids in dietary supplements by LC/MS using a stable-isotope labeled internal standard.

Journal of AOAC International·2001
Same author

Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol.

Biochemical pharmacology·2001

Researchers identified a new mitomycin C (MC) DNA adduct involving adenine, not guanine. This minor adduct may be linked to a major adduct found in cancer cells, warranting further investigation.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Mitomycin C (MC) is a chemotherapeutic agent known to form DNA adducts, primarily at guanine residues.
  • Understanding the full spectrum of MC-DNA adducts is crucial for predicting its efficacy and toxicity.

Purpose of the Study:

  • To identify and characterize novel DNA adducts formed by mitomycin C (MC).
  • To investigate the sequence specificity and structural features of MC adducts with adenine.
  • To compare in vitro findings with in vivo observations of MC adducts in cancer cells.

Main Methods:

  • Isolation and structural elucidation of a novel N6-deoxyadenosine adduct of MC (adduct 8) using spectroscopic and mass spectrometry techniques.
  • Synthesis of oligonucleotide probes to study the specificity of MC alkylation at adenine sites.

Related Experiment Videos

  • Enzymatic digestion and High-Performance Liquid Chromatography (HPLC) analysis to quantify adduct formation.
  • Comparison of HPLC elution profiles with previously identified in vivo adducts.

    • Main Results:

    • The first N6-deoxyadenosine adduct of mitomycin C (adduct 8) was isolated and structurally characterized.
    • Adduct formation at adenine sites was favored in (A)n sequences over (AT)n sequences and occurred preferentially in duplex DNA.
    • Monofunctional alkylation at adenine sites was observed, with an adenine-to-guanine alkylation ratio of 0.03 in calf thymus DNA, indicating adduct 8 is a minor adduct in this system.
    • The HPLC elution time of adduct 8 matched a previously detected major unknown MC adduct in vivo.

    Conclusions:

    • Mitomycin C can form adducts with adenine, expanding the known adduct profile beyond guanine.
    • Adduct 8, although a minor product in vitro, may represent a significant adduct formed in vivo, potentially contributing to the therapeutic or toxic effects of mitomycin C.
    • Further comparative studies are needed to confirm the identity of adduct 8 with the major in vivo adduct.